1. Home
  2. RFL vs OPXS Comparison

RFL vs OPXS Comparison

Compare RFL & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • OPXS
  • Stock Information
  • Founded
  • RFL 2017
  • OPXS 1987
  • Country
  • RFL United States
  • OPXS United States
  • Employees
  • RFL N/A
  • OPXS N/A
  • Industry
  • RFL Real Estate
  • OPXS Electronic Components
  • Sector
  • RFL Finance
  • OPXS Technology
  • Exchange
  • RFL Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • RFL 55.3M
  • OPXS 61.7M
  • IPO Year
  • RFL N/A
  • OPXS N/A
  • Fundamental
  • Price
  • RFL $1.55
  • OPXS $7.22
  • Analyst Decision
  • RFL
  • OPXS
  • Analyst Count
  • RFL 0
  • OPXS 0
  • Target Price
  • RFL N/A
  • OPXS N/A
  • AVG Volume (30 Days)
  • RFL 35.4K
  • OPXS 28.1K
  • Earning Date
  • RFL 12-11-2024
  • OPXS 12-19-2024
  • Dividend Yield
  • RFL N/A
  • OPXS N/A
  • EPS Growth
  • RFL N/A
  • OPXS 61.76
  • EPS
  • RFL N/A
  • OPXS 0.55
  • Revenue
  • RFL $697,000.00
  • OPXS $33,995,000.00
  • Revenue This Year
  • RFL N/A
  • OPXS N/A
  • Revenue Next Year
  • RFL N/A
  • OPXS N/A
  • P/E Ratio
  • RFL N/A
  • OPXS $12.76
  • Revenue Growth
  • RFL 151.62
  • OPXS 32.49
  • 52 Week Low
  • RFL $1.29
  • OPXS $5.14
  • 52 Week High
  • RFL $2.50
  • OPXS $10.30
  • Technical
  • Relative Strength Index (RSI)
  • RFL 35.59
  • OPXS 33.63
  • Support Level
  • RFL $1.52
  • OPXS $6.59
  • Resistance Level
  • RFL $1.96
  • OPXS $9.54
  • Average True Range (ATR)
  • RFL 0.13
  • OPXS 0.72
  • MACD
  • RFL -0.03
  • OPXS -0.18
  • Stochastic Oscillator
  • RFL 12.50
  • OPXS 15.93

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Richardson and Applied Optics Center Dallas. It generates maximum revenue from the Applied Optics Center Dallas segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: